Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from M3 ( (JP:2413) ).
M3, Inc. has completed a share repurchase program authorized by its board, buying back 3,911,900 common shares for about ¥6.44 billion between March 1 and March 13, 2026, via open market purchases on the Tokyo Stock Exchange. Under the broader mandate effective from May 2025 to April 2026, the company has repurchased a total of 11,649,800 shares for nearly ¥20 billion, a move that tightens its share float and may enhance capital efficiency and shareholder value by signaling management’s confidence and active balance sheet management.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen3000.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc., listed on the TSE Prime Market under ticker 2413 and headquartered in Tokyo, operates in the healthcare and medical information services space. The company runs digital platforms and related services targeting medical professionals and institutions, positioning itself as a key player in Japan’s online medical and pharmaceutical information market.
YTD Price Performance: -21.26%
Average Trading Volume: 5,127,408
Technical Sentiment Signal: Sell
Current Market Cap: Yen1130.3B
For detailed information about 2413 stock, go to TipRanks’ Stock Analysis page.